Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections (multiple letters) [1]

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 6, 2004, Pages 1158-

  Frippiat, Frédéric ^a,b   Meunier, Françoise ^a   Derue, Geneviève ^a   Darley, Elizabeth S R ^c   MacGowan, Alasdair P ^c  

^a Centre Hospitalier Jolimont Lobbes   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Bone infections; Joint infections; Moxifloxacin; Rifampicin

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; OXACILLIN; QUINOLONE DERIVATIVE; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; BACTERICIDAL ACTIVITY; BONE INFECTION; BONE PLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEBRIDEMENT; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG PENETRATION; DRUG POTENCY; GRAM POSITIVE BACTERIUM; HUMAN; IN VITRO STUDY; INFECTIOUS ARTHRITIS; KNEE PROSTHESIS; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; OPTIC NERVE DISEASE; OSTEOMYELITIS; PERIPHERAL NEUROPATHY; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTOPENIA;

ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BONE DISEASES, INFECTIOUS; DRUG THERAPY, COMBINATION; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; HUMANS; JOINT DISEASES; MICROBIAL SENSITIVITY TESTS; QUINOLINES; RIFAMPIN;

EID: 12444325563     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh451     Document Type: Letter

References (0)